{"id":56327,"date":"2023-04-28T12:03:12","date_gmt":"2023-04-28T10:03:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/metabolomics-global-market-report-2023-sector-to-reach-4-7-billion-by-2028-at-an-11-85-cagr-researchandmarkets-com\/"},"modified":"2023-04-28T12:03:12","modified_gmt":"2023-04-28T10:03:12","slug":"metabolomics-global-market-report-2023-sector-to-reach-4-7-billion-by-2028-at-an-11-85-cagr-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/metabolomics-global-market-report-2023-sector-to-reach-4-7-billion-by-2028-at-an-11-85-cagr-researchandmarkets-com\/","title":{"rendered":"Metabolomics Global Market Report 2023: Sector to Reach $4.7 Billion by 2028 at an 11.85% CAGR – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.<\/p>\n

<\/a><\/p>\n

\nThe global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.85% during 2022-2028.<\/p>\n

\nMetabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems.<\/p>\n

\nIt consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.<\/p>\n

\nThe increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression.<\/p>\n

\nAdditionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.<\/p>\n

\nKey Market Segmentation:<\/strong><\/p>\n

\nThe publisher provides an analysis of the key trends in each sub-segment of the global metabolomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and application.<\/p>\n

\nBreakup by Product:<\/strong><\/p>\n